Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000963

Drug Information
NameHexafluronium bromide
SynonymsBromuro de hexafluronio; AC1L1T17; Mylaxen; LS-18141; NSC-19477; hexafluorenium; Milaxen; CHEMBL1200933; Hexamethylene bis(9-fluorenyldimethylammonium)dibromide; Esafluronio bromuro; Hexafluronii bromidum; Esafluronio bromuro [DCIT]; Hexafluorenium dibromide; DB00941; CID9434; Hexamethylenebis(9-fluorenyldimethylammonium bromide); IN-117; Bromure d'hexafluronium; 1,6-Bis(9 fluorenyldimethyl-ammonium)hexane bromide; UNII-B64NJG83K2; Hexafluronii bromidum [INN-Latin]; Hexafluorenium bromide [USAN]; Bromuro de hexafluronio [INN-Spanish]; Hexamethylenebis(fluoren-9-yldimethylammonium) dibromide; 9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)azaniumyl]hexyl]-dimethylazanium dibromide; Hexafluronium bromide (INN); Hexamethylenebis(dimethyl-9-fluorenylammonium bromide); AMMONIUM, HEXAMETHYLENEBIS(FLUOREN-9-YLDIMETHYL-, DIBROMIDE; Hexafluronium bromide; Hexafluorenium bromide; N,N'-Di(9-fluorenyl)-N,N,N',N'-tetramethyly-hexamethylendi(ammoniumbromid); Bromure d'hexafluronium [INN-French]; EINECS 206-265-0; 1,6-Hexanediaminium, N,N'-di-9H-fluoren-9-yl-N,N,N',N'-tetramethyl-, dibromide; hexafluorenium dibromide salt; Mylaxen (TN); C36H42N2; Ammonium, hexamethylenebis(fluoren-9-yldimethyl-, bromide; D04435; 4844-10-4 (Parent); 317-52-2; Hexafluorenium bromide (USAN)
IndicationSpasms, Pain
[ICD9: 338,780   ICD10: R52, G89]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(
28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-2
4-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;
;/p-2
InChIKeyWDEFPRUEZRUYNW-UHFFFAOYSA-L
Canonical SMILESC[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=
CC=C46.[Br-].[Br-]    
Therapeutic ClassAnalgesics
CAS NumberCAS 317-52-2
FormulaC36H42Br2N2
PubChem Compound IDCID 9434.
PubChem Substance IDSID 152643.
SuperDrug ATC IDM03AC05
M03AC05
TargetCholinesteraseInhibitor[2]
Ref 1Pharmacology, clinical uses, and adverse effects of ceruletide, a cholecystokinetic agent. Pharmacotherapy. 1982 Jul-Aug;2(4):223-34. To Reference
Ref 2Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats. Acta Anaesthesiol Scand. 1984 Feb;28(1):87-90. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543